Moderna announces a landmark publication describing the first-ever protein production through messenger RNA therapeutics™.
What if there was an entirely new drug modality to enable the body to produce its own healing proteins in vivo?
We are delivering the next wave of innovation to treat serious illness.
Moderna and AstraZeneca have a strategic option agreement to develop up to forty messenger RNA Therapeutics™ for the treatment of serious cardiometabolic diseases and cancer.
We’ve assembled a team of scientists and drug hunters, executives and visionaries. Our experience is matched only by our passion.
We are enabling an entirely new drug modality across a vast range of diseases—many of which cannot be treated with existing drugs.
watch our video
November 20, 2013
Moderna closes new financing round raising $110M. | Read more
October 24, 2013
Moderna named a "Global Growth Company" by the World Economic Forum. I Read more
October 17, 2013
Moderna opens new headquarters and laboratories at 200 Tech Square. I Read more